Rhein, a monomeric anthraquinone obtained from the plant herb species Polygonum multiflorum and P. cuspidatum, has been proposed to have anticancer activity. This activity has been suggested to be associated with mitochondrial injury due to the induction of mitochondrial permeability transition pore (mPTP) opening. In this study, the effects of 5-80 μM rhein on cell viability, half-maximal inhibitory concentration (IC50 value), resistance index, and apoptosis were assessed in the liver cancer cell lines SMMC-7721 and SMMC-7721/DOX (doxorubicin-resistant cells). Rhein (10-80 μM) significantly reduced the viability of both cell lines; 20 μM rhein significantly increased sensitivity to DOX and increased apoptosis in SMMC-7721 cells, but reversed resistance to DOX by 7.24-fold in SMMC-7721/DOX cells. Treatment with rhein increased accumulation of DOX in SMMC-7721/DOX cells, inhibited mitochondrial energy metabolism, decreased cellular ATP, and ADP levels, and altered the ratio of ATP to ADP. These effects may result from the binding of rhein with voltage-dependent ion channels (VDACs), adenine nucleotide translocase (ANT), and cyclophilin D, affecting their function and leading to the inhibition of ATP transport by VDACs and ANT. ATP synthesis was greatly reduced and mitochondrial inner membrane potential decreased. Together, these results indicate that rhein could reverse drug resistance in SMMC-7721/DOX cells by inhibiting energy metabolism and inducing mPTP opening. © 2018 BioFactors, 45(1):85-96, 2019 
Introduction
Abnormal energy metabolism is an important feature of tumor cells [1] [2] [3] and aerobic glycolysis has been considered to be a passive result of mitochondrial dysfunction. However, recent studies have shown that changes to mitochondrial energy metabolism are a manifestation of cell function adjustments, and there appears to be some heterogeneity and plasticity in different tumors and under different conditions [4] [5] [6] . Our previous studies indicated that doxorubicin (DOX)-resistant hepatocellular carcinoma SMMC-7721 cells (SMMC-7721/DOX) use oxidative phosphorylation as an important source of energy metabolism in contrast to their parental cells that use glycolysis as the main energy metabolic source [7] . We suggest that mitochondrial energy metabolism is an important feature of SMMC-7721/DOX cells and offers a potentially important target for therapy.
Rhein is a monomeric anthraquinone that is found in the herb species Polygonum multiflorum and P. cuspidatum and is suggested to exhibit antitumor activity. This activity is postulated to be associated with induction of mitochondrial injury. An earlier report suggested that rhein could cause damage and apoptosis in HepG2 cells by inducing mitochondrial permeability transition pore (mPTP) opening [8] . Rhein was also shown to induce apoptosis in HL-7702 cells via a mitochondrionmediated signaling pathway with overproduction of reactive oxygen species and loss of mitochondrial membrane potential [9] . The cytotoxicity of rhein can be inhibited by cyclosporin A (CsA), which binds to cyclophilin D (CypD) to inhibit mPTP opening [10] . However, the specific target of rhein on the PTP complex remains undefined. It is unclear whether rhein can affect other aspects of mitochondrial energy metabolism in addition to promoting PTP opening, or whether rhein can reverse drug resistance in hepatocellular carcinoma cells. In this study, we sought to answer these questions by investigating the mechanisms by which rhein reverses drug sensitivity in SMMC-7721/DOX cells.
Experimental procedures

Materials
Rhein, ATP, and ADP standards were purchased from the China Pharmaceutical Biology Products Institute (Beijing, China); BCA Protein Assay kit were purchased from Shanghai Biyuntian Biological Co., Ltd, (Shanghai, China). Annexin V-FITC apoptosis detection kit was obtained from Nanjing KeyGen Biotech Co. (Nanjing, China). Mitochondrial stress test kit and glycolysis stress test kit were purchased from Seahorse Bioscience (North Billerica, MA). Verapamil (VRP), 4,4-diisothoocyanatostibene-2, 2-disulfonic acid (DIDS), bongkrekic acid (BA), CsA, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), and rhodamine-1,2,3 (Rh-123) were purchased from Sigma Aldrich Chemical Co. (St Louis, MO). Fetal bovine serum (FBS) and antibiotic-antimycotic solution were procured from Gibco Life Technologies (Grand Island, NY). 
Dynamic monitoring DOX uptake of cells
A further experiment was performed to detect the effect of rhein on the entry of DOX into SMMC-7721/DOX cells at a low concentration (inhibition rate of <20%). VRP was used as a positive control. Briefly, Cells were seeded into 96-well plates at 2 × 10 4 cells/mL, allowed to attach overnight, and treated with DOX(8 μM), in combination with rhein (20 μM) or VRP (10 μM) for 24 h. The red fluorescent in cells generated by DOX was monitored and quantitative analysis by incucyte real-time video imaging system (Essen Instruments, Ann Arbor, MI). The fluorescence intensity units collected from treated cells normalized to untreated controls as changes in total red object integrated intensity.
UPLC-MS/MS detection of intracellular DOX content
Radioimmunoprecipitation assay buffer (100 μL) was added to cells after treatment for 24 h. The protein in cell lysates was precipitated by methanol, and the supernatant obtained by high-speed centrifugation (12000 × g, 10 min, 4 C) was dried with nitrogen and re-dissolved in methanol. 
ATP and ADP detection
At the end of the experiment, cell lysates were prepared by ultrasonic treatment of cells on ice (ultrasonic 2 s, intermittent 2 s, the treatment was performed for a total of 2 min); the lysates were centrifuged at 12000 g for 10 min, and supernatants were analyzed for intracellular ATP and ADP contents by high performance liquid chromatography (HPLC). The intracellular ATP and ADP contents were normalized to total cell protein using the formula: C (μg/mg pro) = composition concentration (μg/ml)/protein concentration (mg/ml).
Chromatographic conditions
A Waters XBridge™ C18 (5 μm, 4.6 mm × 150 mm) and precolumn with the same packing (5 μm, 4.6 mm × 50 mm) were used for the separation. The mobile phase consisted of eluent A: 0.1 mol/L phosphate buffer salt solution (pH 6.15, 0.02 mol/L Na 2 HPO 4 and 0.08 mol/l NaH 2 PO 4 ) and eluent B: methanol (v/v = 99.9:0.1) were prepared before use. The injection volume was 20 μL. A flow rate of 1.0 mL/min was used, the column temperature was maintained at 25 C; the mobile phase was passed through a 0.45-μm membrane filter. The extracellular and intracellular samples were measured at 259 nm.
Mitochondrial stress test and glycolysis stress test
Cells (5 × 10 3 ) were seeded into 96-well plates, allowed to adhere overnight, and then treated with DOX (0.5 μM) or/and rhein (20 μM) for 24 h. The oxygen consumption rate (OCR, pmol/min) and extracellular acidification rate (ECAR, mpH /min) were determined using the Seahorse-XF 96 Extracellular Flux Analyzers from Seahorse Bioscience (North Billerica, MA) following the manufacturer's protocol [11] . Briefly, the cells were re-suspended in the Seahorse assay medium, including MgSO 4 (0.8 mM), CaCl 2 (1.8 mM), NaCl (143 mM), KCl (5.4 mM) NaH 2 PO 4 (0.91 mM), and HEPES (5 mM). And the drugs from the XF Cell Mito Stress test kit (Seahorse Bioscience) were added to the illustrated time points: oligomycin (0.5 μM), FCCP (0.5 μM), and rotenone/antimycin A mix (0.5 μM each). The data were analyzed by XF Wafe software (Seahorse Bioscience). The results were normalized to total cell protein using the formula.
Molecular docking between rhein and selected proteins
The structures of five proteins, namely, adenine nucleotide translocase (ANT), voltage-dependent ion channel (VDAC), cyclophilin D (CypD), peripheral benzodiazepine receptor (PBR), and hexokinase (HK) were obtained from the Protein Data Bank (PDB; http://www.pdb.org). We followed the criteria suggested by the database for downloading three-dimensional crystal structures: if the protein has more than one entry, select the one with highest resolution; if the protein is in a complex and the binding pocket information can be extracted directly from the specific position of ligand, select this PDB entry [12] . The basic information on the receptors for this docking study including name, UniProtKB, PDB code, length, and resolution is listed in Table 2 . The crystal structure coordinates of the receptors were loaded into Discovery Studio 4 software (DS4, Discovery Studio version 2.5, Accelrys Inc., CA, 2009) in the default form for linear structure models and docked with rhein. The ligand molecule of rhein was prepared by ChemBio Draw Ultra 12.0 software as a PDB format, then an energy minimization optimization was carried out, and the optimized conformation was used for docking with the receptors [13] . In brief, the structure of rhein was imported into the dock ligands modeler of DS4 software, and then was aligned to the prepared protein, the most stable structure was selected by the energy score.
The CDOCKER module of DS 4 software was used to dock rhein with the five selected proteins. Partial charges were added to the receptors. Hydrogen atoms were optimized and protonated automatically using the protonation 3D function under the Compute module of the software [14] . The energy of the proteins was minimized using energy minimization [15] and the docking results showing the most favorable binding mode with the highest negative CDOCKER interaction energy values were selected.
Mitochondrial inner membrane potential detection
Mitochondrial inner membrane potential (5Ψm) is one of the important parameters reflecting the functional status of mitochondria. The value represents the degree of openness of mPTP. Under normal conditions, mPTP is transiently open, 5Ψm is high. However, several damage factors could induce sustained PTP opening and 5Ψm decreasing. Therefore, this study used the level of ΔΨm to characterize the degree of openness of mPTP.
In order to further study, the mechanism of rhein affecting mitochondrial function, mitochondrial metabolism and 5Ψm was studied by using selectively inhibitors of different components of the PTP complex: DIDS (50 μM) to inhibit VDACmediated mPTP opening; BA (5 μM) to inhibit ANT-mediated mPTP opening; and CsA (2.5 μM) to inhibit CypD-mediated mPTP opening [16] .
5Ψm was assessed using Rh-123 staining. Briefly, at the end of the experiment, cells were incubated with 5 μM Rh-123 at 37 C for 15 min, then the cells were washed with PBS and viewed under a fluorescence microscope at a wavelength of 535 nm.
Statistical analysis
Statistical analysis was performed using the SPSS15.0 software package. One-way ANOVA was used to analyze the differences between groups. Multiple comparisons were performed by the LSD method. Results are shown as means AE standard deviation (Χ AE S) and P < 0.05 was taken as statistically significant.
Results
Rhein reverses DOX resistance in SMMC-7721/DOX cells
The reduction of cell viability was greater in SMMC-7721/DOX cells than in SMMC-7221 cells after treatment with 0.1-40 μM DOX (P < 0.01; Fig. 1 ). The effect of rhein on cell viability was dose-dependent in the range 5-80 μM, but unlike that observed with DOX, there was no significant difference between the two cell types. From the dose-response curve for SMMC-7721/DOX cells, rhein showed low cytotoxicity (<20%) at doses of 10 and 20 μM.
As is shown in Table 1 , the IC50 for DOX in SMMC-7721 and SMMC-7721/DOX cells was 26.81 AE 1.55 and 152.37 AE 23.41 μM, respectively. The two cell types showed a 5.67-fold difference in drug resistance (P < 0.01). The IC50 for DOX in SMMC-7721/DOX cells decreased after combination with 20 μM rhein and the drug resistance difference between the two cell types decreased ( Table 3 ). The reversal in the sensitivity of SMMC-7721/DOX cells was estimated as 7.24-fold, compared to the 5.97-fold of the positive control VRP.
According to the results of this test, the dose of combined inhibitory effect 20-40% (DOX: 8 μM, rhein: 20 μM) was selected in the following experiments.
Rhein increases DOX accumulation in SMMC-7721 and SMMC-7721/DOX cells and promotes apoptosis
The accumulation of intracellular DOX was assessed using a living cell imaging analysis system and the UPLC-MS/MS method. After a 10-h incubation, the amount of intracellular DOX in SMMC-7721 and SMMC-7721/DOX cells reached a peak and remained unchanged for up to 24 h. Rhein treatment increased the maximum level of DOX and also increased the rate of accumulation of DOX in both cell types (Fig. 2A) . The positive control VRP [17] 49.15 AE 9.24 and 87.88 AE 9.57 ng/mg protein, respectively, after 24 h; treatment with rhein increased intracellular DOX contents to 79.44 AE 13.06 and 104.31 AE 7.76 ng/mg protein, respectively (P < 0.01; Fig. 2B ).
In addition to an increased intracellular level of DOX, the rate of apoptosis in SMMC-7721/DOX cells increased (P < 0.01; Figs. 2C and 2D ). These results suggest that rhein could significantly promote DOX-induced apoptosis in the drug-resistant cells.
Effects of rhein on energy metabolism phenotypes of SMMC-7721 and SMMC-7721/DOX cells
Next, we investigated changes in ATP and ADP levels in the two cell types after DOX or rhein treatment. The ATP and ADP levels and the ATP/ADP ratio in SMMC-7721/DOX cells were higher than those in SMMC-7721 cells. DOX caused an increase in ATP and the ATP/ADP ratio in SMMC-7721 cells (P < 0.05, P < 0.01, respectively; Fig. 3A ), but had no significant effect in SMMMC-7721/DOX cells. Rhein significantly decreased the level of ATP in both cell types, particularly in SMMC-7721/DOX cells. In the latter, ATP levels were one-fifth of those in the DOXtreated group. The ratio of ATP/ADP also decreased after rhein treatment (P < 0.01; Fig. 3A ). VRP had no significant impact on the levels of ATP or ADP.
In the mitochondrial stress test (Figs. 3B and 3C ), the basal OCR was greater in SMMC-7721/DOX cells than in SMMC-7721 cells. After treatment with oligomycin, an inhibitor of ATP synthase, the OCR was reduced in both cell types, although this reduction was greater for the SMMC-7721/DOX cells, indicating that they had higher ATP synthase activity and, thereby, had an increased mitochondrial ATP production. In response to treatment with carbonyl cyanide-4-(trifluoromethoxy) phenylhydrazone (FCCP), the OCR increased in both cell types; maximal respiration was greater in SMMC-7721/DOX cells than in SMMC-7721 cells, indicating that the former had a larger spare respiratory capacity for oxidative phosphorylation. Low doses of DOX significantly increased basal OCR in both cell types (P < 0.05 in SMMC-7721 cells and P < 0.01 in SMMC-7721/DOX cells; Figs. 3B and 3C ). In SMMC-7721/DOX cells, ATP production capacity and maximal oxygen consumption also increased significantly (P < 0.01, P < 0.05; Figs. 3B and 3C) . However, treatment with rhein reversed basal OCR, ATP production capacity, and maximum oxygen consumption in SMMC-7721/ DOX cells (P < 0.01; Figs. 3B and 3C), suggesting that it significantly reduced mitochondrial energy metabolism in these cells. In the glycolysis stress test (Figs. 3D and 3E ), the ECAR increased in the culture media of the two cell types, providing evidence for glycolysis. In response to treatment with oligomycin, a significantly larger increase in ECAR was found for SMMC-7721/DOX cells than SMMC-7721 cells, suggesting that the former had a greater glycolytic capacity when oxidative phosphorylation was inhibited. In response to 2-deoxy-D-glucose, glycolysis was significantly inhibited in both cell types.
All these results suggest that both cell types had glycolysis and oxidative phosphorylation modes of energy metabolism; however, SMMC-7721 cells were dominated by glycolysis, whereas oxidative phosphorylation was significantly increased in SMMC-7721/DOX cells and was the major contributor to the higher ATP level of these cells compared to SMMC-7721 cells. Treatment of SMMC-7721 cells with a low dose of DOX might stimulate oxidative phosphorylation and glycolysis metabolism, and raise the level of ATP and increase the ATP/ADP ratio; Treatment with rhein in addition to DOX, however, decreased ATP levels in both cell types by inhibiting oxidative phosphorylation.
3.4. Molecular docking study of rhein with the respiratory chain complex and mitochondrial permeability transition pore (mPTP) complex
As described in the previous section, rhein suppressed oxidative phosphorylation, decreased the level of ATP, and reduced the ATP/ADP ratio in both cell types (Fig. 3) However, rhein did not influence the protein expression level of mitochondrial respiratory chain complex after 24 h incubation (data not shown). So, we studied the effect of rhein on the function of the respiratory chain complex and the mPTP complex, composed mainly of VDAC, ANT, CYPD, PBR, and HK, which affects oxidative phosphorylation by mediating ATP/ADP exchange between the mitochondrial matrix and the cytoplasm. A molecular docking analysis was performed to determine whether rhein can bind to active sites on respiratory chain complex I(CI), complex II (CII), complex III(CIII), complex IV(CIV), complex V(CV), VDAC, ANT, CYPD, PBR, and HK. First, the binding energies of receptors interacting with rhein were evaluated. This showed that rhein took the most favorable conformation to bind with the receptors on CI, CV, VDAC, ANT, CYPD, and PBR within the binding pockets; however, there was no proper binding site on CII, CIII, CIV, and HK. The strength of the binding affinity between a receptor and rhein can be assessed by the size of the negative CDOCKER interaction energy value. We found that the binding affinities of the six candidate proteins and rhein ranked in descending order were VDAC > ANT > CYPD > PBR > CI > CV; the scores for the four receptors with rhein were more negative than the minimum threshold (London dG < 7.5 kcal/mol) ( Table 4 ) [18] .
The optimal binding modes of rhein for each receptor are presented in Table 5 and Fig. 4 ; the stability of the receptor and rhein complexes was mainly sustained by four types of molecular interaction, namely, van der Waals, hydrogen bonds, covalent bonds, and ionic bonds. For respiratory chain complex, rhein could form two types of interaction with CI (van der Waals, hydrogen bonds) and CV (hydrogen bonds, covalent bonds). This result partially explained the inhibition mechanism of mitochondrial energy metabolism by rhein.
For mPTP complex, rhein formed three types of interaction with VDAC, CYPD, and PBR (hydrogen bonds, covalent bonds, ionic bonds), and three types of interaction with ANT (van der Waals, covalent bonds, ionic bonds). When the backbone amino residues participated in forming hydrogen bonds with rhein, the interactions contributed to increased stability of the receptor-ligand complex compared to that achieved by sidechain hydrogen bonds with side-chain amino residues (Figs. 4A and 4B).
Rhein inhibits mitochondrial energy metabolism partly through VDAC and ANT in SMMC-7721 and SMMC-7721/DOX cells
According to our docking analysis, rhein acted not only on the respiratory chain CI and C5, inhibited ATP synthesis directly, but also possessed strong binding affinity with four components of the PTP complex. In order to understand how rhein affects mitochondrial metabolism, we used inhibitors DIDS (50 μM), BA (5 μM), CsA (2.5 μM) that selectively inhibited different components of the PTP complex. The analyses showed that DIDS and BA reverse the decreased ATP level and reduced ATP/ADP ratio caused by rhein in both cell types (P < 0.01 versus rhein; Fig. 5A3 ). DIDS and BA also restored mitochondrial energy metabolism that had been inhibited by rhein in both cells (Figs. 5B and 5C); the strength of this effect was DIDS > BA, which could restore ATP production, maximal respiration and spare capacity of SMMC-7721/DOX cells. In contrast, both inhibitors had weak effects in SMMC-7721 cells. CsA had no significant effect on rhein-induced changes in mitochondrial energy metabolism. These results indicated that rhein inhibited mitochondrial energy metabolism primarily through VDAC and ANT in SMMC-7721/DOX cells. 3.6. Rhein decreases mitochondrial inner membrane potential (5Ψm) through VDAC, ANT, and CypD in both cell types
The effect of rhein on mitochondrial function in SMMC-7721 and SMMC-7721/DOX cells was investigated by Rh-123 staining and measuring Δψm as fluorescence intensity. When the cells were exposed to rhein for 24 h, the mitochondrial membranes were depolarized and the fluorescence intensity increased significantly (P < 0.01 vs control; Figs. 6A and 6B). Pretreatment with DIDS, BA, or CsA reduced fluorescence intensity in both cell types (P < 0.05 and P < 0.01 vs rhein), suggesting that rhein decreased 5Ψm through VDAC, ANT, and CypD simultaneously in both cell types.
Discussion
The mPTP complex is composed of several proteins and is located between the inner and outer membranes of mitochondria, it is a component of a nonspecific pathway whose molecular composition has not yet been fully studied. The classical structural model suggests that mPTP is composed of VDAC, ANT, CypD receptor, HK, and PBRs. VDAC is a channel protein that mediates the direct exchange of metabolites such as pyruvate, malate, and glutamate. In combination with VDAC, ANT mediates ATP and ADP translocation between the cytoplasm and mitochondria, providing the raw material (ADP) for mitochondrial oxidative phosphorylation. The rate of adenylate exchange through ANT and VDAC plays a key role in # P < 0.05, ## P < 0.01 compared with control group; * P < 0.05, ** P < 0.01 compared with DOX group.
mitochondrial energy generation and utilization, which directly affects the energy metabolic phenotype of cells. Under physiological conditions, mPTP is opened periodically to allow nonselective passage of water and molecules with a mass < 1.5 × 10 3 to maintain the electrochemical balance within the mitochondria; protons are free to pass through the mitochondrial inner membrane and cause the potential difference inside and outside the mitochondria to form a stable mitochondrial membrane potential. A variety of exogenous pathological stimuli can alter mPTP protein function, for example oxidative stress, ATP and ADP depletion. CYPD has ANT binding sites, and when ADP is depleted in the matrix, CYPD could bind to ANT, and modulate ANT change from a nucleotide transporter to a non-specific transition pore, and causing mPTP opening [19, 20] , inhibiting the release of ATP, the uptake of ADP, and the energy metabolism, which is believed to be one of the causes of increased apoptosis [21, 22] . At the same time, multiple VDAC molecules may form larger channels by oligomerization, causing the release of cytochrome C and other apoptotic factors, which also could cause cell apoptosis [23] .
The structure of rhein contains several carboxyl and phenolic hydroxyl groups that can interact with metal ions in the target enzymes to form stable chelates; this characteristic is an important reason for its wide biological functions. Through molecular docking analysis, rhein was shown to bind with CI, CV, VDAC, ANT, CYPD, and PYB via various forces including electrostatic, London dispersion forces-van der Waals, hydrogen binding, or some combination of these. We further confirmed that rhein acted on SMMC-7721 sensitive and resistant cells through CI, CV, VDAC, ANT, and CYPD to suppress mitochondrial energy metabolism, reducing ATP levels, and that these effects caused the opening of mPTP. The opening of mPTP allowed non-selective release of several substances, which caused the collapse of the mitochondrial membrane potential, uncoupling of oxidative phosphorylation, and disrupted ATP production [24] . Swelling of the mitochondrial matrix induced by rhein caused rupture of the mitochondrial outer membrane and promoted release of cytochrome C and other pro-apoptotic factors into the cytoplasm, to initiate apoptosis in both cell types (Fig. 7) . In glycolysis-dependent cells, the binding between HK and VDAC is an important factor in maintaining glycolysis; the ATP produced in this reaction enters the mitochondria through mPTP and inhibits mitochondrial energy metabolism [25] . Additionally, HK and VDAC binding may also help to maintain the mitochondrial membrane potential. In this study, rhein was found to cause dissociation of binding between VDAC and HK, which may be one of the important reasons for reducing ATP in sensitive cells and inducing apoptosis [26, 27] .
In conclusion, the anticancer effect of rhein is a multitarget effect by its several active groups, by inhibiting energy metabolism and inducing mPTP opening.
